![](https://webarchive.library.unt.edu/eot2008/20081012000806im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/eot2008/20081012000806im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/eot2008/20081012000806im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/eot2008/20081012000806im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081012000806im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081012000806im_/http://www.nci.nih.gov/images/spacer.gif)
| Sustancia en estudio para el tratamiento de algunos tipos de cáncer. El itrio Y 90 edotreotida contiene itrio Y 90 (una forma radiactiva del metal itrio) adherido a una molécula que se une a ciertos tumores neuroendocrinos (tumores que se originan en células que liberan hormonas). La radiactividad del itrio Y 90 puede destruir las células cancerosas. También se llama itrio Y 90 SMT 487 e itrio Y 90-DOTA-tyr3-octreotida. |
![](https://webarchive.library.unt.edu/eot2008/20081012000806im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081012000806im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081012000806im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081012000806im_/http://www.nci.nih.gov/images/spacer.gif) |